🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Eli Lilly Nederland B.V. — Licensed Medicines

98 medicines held by Eli Lilly Nederland B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 98 products held by Eli Lilly Nederland B.V.
MedicineActive substanceLicence holderStatus
100 units/mL Tempo Pen solution for injection in pre-filled pen
EU/1/20/1422/016-017
Insulin lispro Eli Lilly Nederland B.V.
200 units/mL KwikPen solution for injection in pre-filled pen
EU/1/20/1422/013-015
Insulin lispro Eli Lilly Nederland B.V.
ABASAGLAR 100 units/mL solution for injection in a cartridge
EU/1/14/944/001-004
Insulin glargine Eli Lilly Nederland B.V.
ABASAGLAR 100 units/mL solution for injection in a pre-filled pen
EU/1/14/944/005-008
Insulin glargine Eli Lilly Nederland B.V.
Adcirca (previously Tadalafil Lilly)
EU/1/08/476/001-004
Tadalafil Eli Lilly Nederland B.V.
Adcirca 20 mg film-coated tablets
EU/1/08/476/005-06
Tadalafil Eli Lilly Nederland B.V.
Alimta
EU/1/04/290/002
Pemetrexed Eli Lilly Nederland B.V.
Alimta 500 mg powder for concentrate for solution for infusion
EU/1/04/290/001
Pemetrexed Eli Lilly Nederland B.V.
Amyvid 1,900 MBq/mL solution for injection
EU/1/12/805/003-004
Florbetapir (18f) Eli Lilly Nederland B.V.
Amyvid 800 MBq/mL solution for injection
EU/1/12/805/001-002
Florbetapir (18f) Eli Lilly Nederland B.V.
CIALIS
EU/1/02/237/1-5
Tadalafil Eli Lilly Nederland B.V.
Cialis 2.5 mg film-coated tablets
EU/1/02/237/006
Tadalafil Eli Lilly Nederland B.V.
Cialis 5 mg film-coated tablets
EU/1/02/237/7-8
Tadalafil Eli Lilly Nederland B.V.
Cymbalta 30 mg hard gastro-resistant capsules
EU/1/04/296/1-4
Duloxetine hydrochloride Eli Lilly Nederland B.V.
Cymbalta 60 mg hard gastro-resistant capsules
EU/1/04/296/002-005
Duloxetine Eli Lilly Nederland B.V.
Cyramza 10 mg/ml Concentrate for solution for infusion
EU/1/14/957/001-003
Ramucirumab Eli Lilly Nederland B.V.
Duloxetine Lilly 30 mg hard gastro-resistant capsules
EU/1/14/972/001-003
Duloxetine hydrochloride Eli Lilly Nederland B.V.
Duloxetine Lilly 60 mg hard gastro-resistant capsules
EU/1/14/972/005-009
Duloxetine hydrochloride Eli Lilly Nederland B.V.
Emgality
EU/1/18/1330/001-004
GALCANEZUMAB Eli Lilly Nederland B.V.
Forsteo 20 micrograms/80 microliters solution for injection in pre-filled pen
EU/1/03/247/01-2
Teriparatide Eli Lilly Nederland B.V.
Humalog
EU/1/96/007/019
Insulin lispro Eli Lilly Nederland B.V.
Humalog 100 units/ml solution for injection in cartridge insulin lispro
EU/1/96/007/004
Insulin lispro Eli Lilly Nederland B.V.
Humalog 100 units/ml solution for injection in vial
EU/1/96/007/002
Insulin lispro Eli Lilly Nederland B.V.
Humalog Mix25 100 units/ml suspension for injection in cartridge
EU/1/96/007/008
Insulin lispro Eli Lilly Nederland B.V.
Humalog Mix25 100 units/ml suspension for injection in vial
EU/1/96/007/005
Insulin lispro Eli Lilly Nederland B.V.
Humalog Mix50 100 units/ml suspension for injection in cartridge
EU/1/96/007/006
Insulin lispro Eli Lilly Nederland B.V.
Humalog NPL
EU/1/96/007/010
Insulin lispro Eli Lilly Nederland B.V.
Humulin I (Isophane) 100 IU/ml Suspension for Injection in cartridge
PA2276/002/004
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial
PA2276/002/003
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Not marketed
Humulin I KwikPen (Isophane) 100 IU/ml Suspension for Injection
PA2276/005/002
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge
PA2276/003/004
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in vial
PA2276/003/003
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Not marketed
Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection
PA2276/006/002
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Humulin S (Soluble) 100 IU/ml Solution for Injection in vial
PA2276/001/003
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Not marketed
Humulin S (Soluble), 100 IU/ml Solution for Injection in cartridge
PA2276/001/004
Human insulin (recombinant dna origin) Eli Lilly Nederland B.V. Marketed
Jaypirca 100 mg film-coated tablets
EU/1/23/1738/004-009
Pirtobrutinib Eli Lilly Nederland B.V.
Jaypirca 50 mg film-coated tablets
EU/1/23/1738/001-003
Pirtobrutinib Eli Lilly Nederland B.V.
Kisunla 350 mg concentrate for solution for infusion
EU/1/25/1926/001-002
Donanemab Eli Lilly Nederland B.V.
Lartruvo
EU/1/16/1143/001
Olaratumab Eli Lilly Nederland B.V.
Liprolog
EU/1/01/195/22-27
Insulin lispro Eli Lilly Nederland B.V.
Liprolog 100 units/ml, solution for injection in vial
EU/1/01/195/001
Insulin lispro Eli Lilly Nederland B.V.
Liprolog 100 units/ml, solution for injection in vial
EU/1/01/195/002
Insulin lispro Eli Lilly Nederland B.V.
Liprolog Mix25
EU/1/01/195/003
Insulin lispro Eli Lilly Nederland B.V.
Liprolog Mix25 Pen
EU/1/01/195/006
Insulin lispro Eli Lilly Nederland B.V.
Liprolog Mix50
EU/1/01/195/004
Insulin lispro Eli Lilly Nederland B.V.
Liprolog Mix50 Pen
EU/1/01/195/007
Insulin lispro Eli Lilly Nederland B.V.
Liprolog-Pen
EU/1/01/195/005
Insulin lispro Eli Lilly Nederland B.V.
Lyumjev
EU/1/20/1422/001-012
Insulin lispro Eli Lilly Nederland B.V.
Mounjaro 10 mg solution for injection in pre-filled pen
EU/1/22/1685/010-012
Tirzepatide Eli Lilly Nederland B.V.
Mounjaro 10 mg/dose KwikPen solution for injection in pre-filled pen
EU/1/22/1685/055-056
Tirzepatide Eli Lilly Nederland B.V.
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.